CompanyDeals

Simcere Receives $40M Milestone from AbbVie for Trispecific Myeloma Drug

CompanyDeals

Medtronic to Acquire CathWorks for $585M, Expand AI-Based FFRangio System

TenNor Therapeutics Files Hong Kong IPO for Anti-Infective Pipeline
CompanyDeals

TenNor Therapeutics Files Hong Kong IPO for Anti-Infective Pipeline

CompanyDrug

BeBetter Med BEBT-701 Approved for Hypertension siRNA Trial

AbbVie Files Rinvoq for Vitiligo Approval in US and EU
CompanyDrug

AbbVie Files Rinvoq for Vitiligo Approval in US and EU

Datroway TNBC sBLA Gets FDA Priority Review for Triple-Negative Breast Cancer
CompanyDrug

Datroway TNBC sBLA Gets FDA Priority Review for Triple-Negative Breast Cancer

Bayer Nubeqa Gets NMPA Approval for Metastatic Prostate Cancer
CompanyDrug

Bayer Nubeqa Gets NMPA Approval for Metastatic Prostate Cancer

Company

Daiichi Sankyo Discontinues DS-9606 ADC, Delays Dato-DXd Data

CompanyDeals

Insilico Medicine Doses First Patient in MEN2501 Phase I, Triggers $5M Menarini Milestone

PrimeGenX Therapeutics Files Hong Kong IPO for Pumecitinib Platform
CompanyDeals

PrimeGenX Therapeutics Files Hong Kong IPO for Pumecitinib Platform

CompanyMedical Device

Hengrui Resubmits Camrelizumab-Apatinib BLA for HCC to FDA

CompanyDeals

Jumpcan Licenses PrimeGenX Pumecitinib Nasal Spray for Allergic Rhinitis